Published in Lancet on June 13, 1998
The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology. Clin Exp Immunol (2003) 2.18
A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice. Infect Immun (1999) 2.13
Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malar J (2008) 2.00
Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malar J (2007) 1.97
Low interleukin-12 activity in severe Plasmodium falciparum malaria. Infect Immun (2000) 1.94
The anaemia of Plasmodium vivax malaria. Malar J (2012) 1.82
Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria. PLoS Pathog (2009) 1.81
Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculature. Infect Immun (2000) 1.70
Severe malarial anemia: innate immunity and pathogenesis. Int J Biol Sci (2011) 1.65
IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection. J Immunol (2011) 1.56
Combinations of host biomarkers predict mortality among Ugandan children with severe malaria: a retrospective case-control study. PLoS One (2011) 1.55
Cytokine-associated neutrophil extracellular traps and antinuclear antibodies in Plasmodium falciparum infected children under six years of age. Malar J (2008) 1.45
Distinct mechanisms of inadequate erythropoiesis induced by tumor necrosis factor alpha or malarial pigment. PLoS One (2015) 1.42
Severe malarial anemia of low parasite burden in rodent models results from accelerated clearance of uninfected erythrocytes. Blood (2005) 1.39
Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease. Annu Rev Immunol (2014) 1.38
Maternal peripheral blood level of IL-10 as a marker for inflammatory placental malaria. Malar J (2008) 1.37
Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemia. Infect Immun (2006) 1.36
Acquisition of hemozoin by monocytes down-regulates interleukin-12 p40 (IL-12p40) transcripts and circulating IL-12p70 through an IL-10-dependent mechanism: in vivo and in vitro findings in severe malarial anemia. Infect Immun (2006) 1.26
Geographical and temporal conservation of antibody recognition of Plasmodium falciparum variant surface antigens. Infect Immun (2004) 1.24
Hemozoin (malarial pigment) directly promotes apoptosis of erythroid precursors. PLoS One (2009) 1.21
Patent filarial infection modulates malaria-specific type 1 cytokine responses in an IL-10-dependent manner in a filaria/malaria-coinfected population. J Immunol (2009) 1.21
Cytokines in the pathogenesis of and protection against malaria. Clin Diagn Lab Immunol (2002) 1.20
Bone marrow suppression and severe anaemia associated with persistent Plasmodium falciparum infection in African children with microscopically undetectable parasitaemia. Malar J (2005) 1.18
Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta. PLoS Pathog (2009) 1.14
CD4+ CD25+ Foxp3+ regulatory T cells, dendritic cells, and circulating cytokines in uncomplicated malaria: do different parasite species elicit similar host responses? Infect Immun (2010) 1.14
Anemia and interleukin-10, tumor necrosis factor alpha, and erythropoietin levels among children with acute, uncomplicated Plasmodium falciparum malaria. Clin Diagn Lab Immunol (2001) 1.10
Cytokine responses to Plasmodium falciparum liver-stage antigen 1 vary in rainy and dry seasons in highland Kenya. Infect Immun (2000) 1.10
P. falciparum infection durations and infectiousness are shaped by antigenic variation and innate and adaptive host immunity in a mathematical model. PLoS One (2012) 1.09
Similar cytokine responses and degrees of anemia in patients with Plasmodium falciparum and Plasmodium vivax infections in the Brazilian Amazon region. Clin Vaccine Immunol (2008) 1.07
CyProQuant-PCR: a real time RT-PCR technique for profiling human cytokines, based on external RNA standards, readily automatable for clinical use. BMC Immunol (2005) 1.06
Elevated levels of IL-10 and G-CSF associated with asymptomatic malaria in pregnant women. Infect Dis Obstet Gynecol (2010) 1.05
Levels of soluble CD163 and severity of malaria in children in Ghana. Clin Vaccine Immunol (2008) 1.02
Networking the host immune response in Plasmodium vivax malaria. Malar J (2013) 1.02
Identification of inflammatory biomarkers for pediatric malarial anemia severity using novel statistical methods. Infect Immun (2011) 1.02
Mannose-binding lectin is a disease modifier in clinical malaria and may function as opsonin for Plasmodium falciparum-infected erythrocytes. Infect Immun (2003) 1.01
Cytokine production and apoptosis among T cells from patients under treatment for Plasmodium falciparum malaria. Clin Exp Immunol (2002) 1.01
Hepatitis B infection is associated with asymptomatic malaria in the Brazilian Amazon. PLoS One (2011) 1.00
Interleukin-10 (IL-10) polymorphisms are associated with IL-10 production and clinical malaria in young children. Infect Immun (2012) 0.99
Candidate human genetic polymorphisms and severe malaria in a Tanzanian population. PLoS One (2012) 0.99
Proinflammatory and regulatory cytokines and chemokines in infants with uncomplicated and severe Plasmodium falciparum malaria. Clin Exp Immunol (2011) 0.98
Cerebral edema and cerebral hemorrhages in interleukin-10-deficient mice infected with Plasmodium chabaudi. Infect Immun (2004) 0.98
The mucosal inflammatory response to non-typhoidal Salmonella in the intestine is blunted by IL-10 during concurrent malaria parasite infection. Mucosal Immunol (2014) 0.98
Complement activation in Ghanaian children with severe Plasmodium falciparum malaria. Malar J (2007) 0.97
Stuck in a rut? Reconsidering the role of parasite sequestration in severe malaria syndromes. Trends Parasitol (2013) 0.97
Immunoglobulin G isotype responses to variant surface antigens of Plasmodium falciparum in healthy Gabonese adults and children during and after successive malaria attacks. Infect Immun (2004) 0.97
Relation of anti- to pro-inflammatory cytokine ratios with acute myocardial infarction. Korean J Intern Med (2010) 0.95
Distinct clinical and immunologic profiles in severe malarial anemia and cerebral malaria in Zambia. J Infect Dis (2011) 0.95
Malaria-related anaemia: a Latin American perspective. Mem Inst Oswaldo Cruz (2011) 0.95
Exposure, infection, systemic cytokine levels and antibody responses in young children concurrently exposed to schistosomiasis and malaria. Parasitology (2011) 0.93
The CD14+CD16+ inflammatory monocyte subset displays increased mitochondrial activity and effector function during acute Plasmodium vivax malaria. PLoS Pathog (2014) 0.92
The severity of malarial anaemia in Plasmodium chabaudi infections of BALB/c mice is determined independently of the number of circulating parasites. Malar J (2008) 0.92
Adverse environmental conditions influence age-related innate immune responsiveness. Immun Ageing (2009) 0.89
Relationship between plasma Interleukin-12 (IL-12) and IL-18 levels and severe malarial anemia in an area of holoendemicity in western Kenya. Clin Diagn Lab Immunol (2003) 0.89
Role of interleukin-10 in malaria: focusing on coinfection with lethal and nonlethal murine malaria parasites. J Biomed Biotechnol (2011) 0.89
Stability of interferon-gamma and interleukin-10 responses to Plasmodium falciparum liver stage antigen 1 and thrombospondin-related adhesive protein immunodominant epitopes in a highland population from Western Kenya. Am J Trop Med Hyg (2009) 0.89
Insights into deregulated TNF and IL-10 production in malaria: implications for understanding severe malarial anaemia. Malar J (2012) 0.88
Human genetic polymorphisms in the Knops blood group are not associated with a protective advantage against Plasmodium falciparum malaria in Southern Ghana. Malar J (2013) 0.87
Immunogenicity and antigenicity of Plasmodium vivax merozoite surface protein 10. Parasitol Res (2014) 0.86
Cachexia in malaria and heart failure: therapeutic considerations in clinical practice. Postgrad Med J (2004) 0.85
Parasite virulence, co-infections and cytokine balance in malaria. Pathog Glob Health (2014) 0.84
Improvement of the efficacy of dihydroartemisinin with atorvastatin in an experimental cerebral malaria murine model. Malar J (2013) 0.84
Immunomodulation in Plasmodium falciparum malaria: experiments in nature and their conflicting implications for potential therapeutic agents. Expert Rev Anti Infect Ther (2012) 0.83
Plasma concentration of malaria parasite-derived macrophage migration inhibitory factor in uncomplicated malaria patients correlates with parasitemia and disease severity. Clin Vaccine Immunol (2010) 0.83
Cytokine profiles at birth predict malaria severity during infancy. PLoS One (2013) 0.82
Body iron delocalization: the serious drawback in iron disorders in both developing and developed countries. Pathog Glob Health (2012) 0.81
Interleukin-10 regulates hepcidin in Plasmodium falciparum malaria. PLoS One (2014) 0.81
Cytokine response to pregnancy-associated recrudescence of Plasmodium berghei infection in mice with pre-existing immunity to malaria. Malar J (2013) 0.80
High plasma levels of soluble intercellular adhesion molecule (ICAM)-1 are associated with cerebral malaria. PLoS One (2013) 0.80
Intermittent preventive treatment with sulfadoxine-pyrimethamine does not modify plasma cytokines and chemokines or intracellular cytokine responses to Plasmodium falciparum in Mozambican children. BMC Immunol (2012) 0.80
Association of high plasma TNF-alpha levels and TNF-alpha/IL-10 ratios with TNF2 allele in severe P. falciparum malaria patients in Sri Lanka. Pathog Glob Health (2013) 0.79
Endothelial cells potentiate interferon-γ production in a novel tripartite culture model of human cerebral malaria. PLoS One (2013) 0.78
Cytokine Profiles in Malawian Children Presenting with Uncomplicated Malaria, Severe Malarial Anemia, and Cerebral Malaria. Clin Vaccine Immunol (2017) 0.77
Chitinase 3-like 1 is induced by Plasmodium falciparum malaria and predicts outcome of cerebral malaria and severe malarial anaemia in a case-control study of African children. Malar J (2014) 0.77
Evidence of IL-17, IP-10, and IL-10 involvement in multiple-organ dysfunction and IL-17 pathway in acute renal failure associated to Plasmodium falciparum malaria. J Transl Med (2015) 0.76
Cytokine response during non-cerebral and cerebral malaria: evidence of a failure to control inflammation as a cause of death in African adults. PeerJ (2016) 0.76
IFN-γ Priming Effects on the Maintenance of Effector Memory CD4(+) T Cells and on Phagocyte Function: Evidences from Infectious Diseases. J Immunol Res (2015) 0.76
Fetal origins of malarial disease: cord blood cytokines as risk markers for pediatric severe malarial anemia. J Infect Dis (2014) 0.76
A STAT6 Intronic Single-Nucleotide Polymorphism is Associated with Clinical Malaria in Ghanaian Children. Genet Epigenet (2016) 0.75
Plasma levels of eight different mediators and their potential as biomarkers of various clinical malaria conditions in African children. Malar J (2016) 0.75
Increased levels of soluble CD30 in plasma of patients with Plasmodium falciparum malaria. Clin Diagn Lab Immunol (2002) 0.75
The Plasmodium falciparum Antigen MB2 Induces Interferon-γ and Interleukin-10 Responses in Adults in Malaria Endemic Areas of Western Kenya. J Glob Infect Dis (2013) 0.75
Lactate levels in severe malarial anaemia are associated with haemozoin-containing neutrophils and low levels of IL-12. Malar J (2006) 0.75
Age-related pattern and monocyte-acquired haemozoin associated production of erythropoietin in children with severe malarial anaemia in Ghana. BMC Res Notes (2014) 0.75
Severe anemia in Malawian children. Malawi Med J (2016) 0.75
Erythropoiesis in Malaria Infections and Factors Modifying the Erythropoietic Response. Anemia (2016) 0.75
Polymorphisms in the Haem Oxygenase-1 promoter are not associated with severity of Plasmodium falciparum malaria in Ghanaian children. Malar J (2015) 0.75
A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan. J Immunol (1998) 2.94
Malaria-related beliefs and behaviour in southern Ghana: implications for treatment, prevention and control. Trop Med Int Health (1997) 2.87
Detection of antibodies to variant antigens on Plasmodium falciparum-infected erythrocytes by flow cytometry. Cytometry (1999) 2.87
Detection of very low level Plasmodium falciparum infections using the nested polymerase chain reaction and a reassessment of the epidemiology of unstable malaria in Sudan. Am J Trop Med Hyg (1996) 2.72
Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. J Infect Dis (2002) 2.61
Levels of antibody to conserved parts of Plasmodium falciparum merozoite surface protein 1 in Ghanaian children are not associated with protection from clinical malaria. Infect Immun (1999) 2.16
Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia. J Infect Dis (2001) 2.15
The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin Exp Immunol (1992) 1.98
Antibodies to variable Plasmodium falciparum-infected erythrocyte surface antigens are associated with protection from novel malaria infections. Immunol Lett (2000) 1.89
Epstein-Barr virus RNA in Burkitt tumor tissue. Cell (1979) 1.88
Naturally acquired antibodies to the glutamate-rich protein are associated with protection against Plasmodium falciparum malaria. J Infect Dis (2000) 1.76
Fibrin-degradation products in cerebral malaria. Lancet (1972) 1.69
Antibodies to variant antigens on the surfaces of infected erythrocytes are associated with protection from malaria in Ghanaian children. Infect Immun (2001) 1.69
Anti-phospholipid antibodies in patients with Plasmodium falciparum malaria. Immunology (1993) 1.64
Lack of association between maternal antibody and protection of African infants from malaria infection. Infect Immun (2000) 1.64
Nine-year longitudinal study of antibodies to variant antigens on the surface of Plasmodium falciparum-infected erythrocytes. Infect Immun (1999) 1.59
Severe anemia in young children after high and low malaria transmission seasons in the Kassena-Nankana district of northern Ghana. Am J Trop Med Hyg (2000) 1.58
Health centre versus home presumptive diagnosis of malaria in southern Ghana: implications for home-based care policy. Trans R Soc Trop Med Hyg (2000) 1.58
Incidence of symptomatic and asymptomatic Plasmodium falciparum infection following curative therapy in adult residents of northern Ghana. Am J Trop Med Hyg (2001) 1.57
Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity. Immunology (1994) 1.55
Do maternally acquired antibodies protect infants from malaria infection? Parasite Immunol (2001) 1.53
The epidemiology of febrile malaria episodes in an area of unstable and seasonal transmission. Trans R Soc Trop Med Hyg (2001) 1.53
Anaemia caused by asymptomatic Plasmodium falciparum infection in semi-immune African schoolchildren. Trans R Soc Trop Med Hyg (2000) 1.49
Seasonal changes in the Plasmodium falciparum population in individuals and their relationship to clinical malaria: a longitudinal study in a Sudanese village. Parasitology (1998) 1.48
Rapid reemergence of T cells into peripheral circulation following treatment of severe and uncomplicated Plasmodium falciparum malaria. Infect Immun (1997) 1.45
Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum. Infect Immun (2001) 1.44
Evidence of endothelial inflammation, T cell activation, and T cell reallocation in uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg (1994) 1.42
Reversible suppression of bone marrow response to erythropoietin in Plasmodium falciparum malaria. Br J Haematol (1997) 1.41
Malaria in urban and rural areas of southern Ghana: a survey of parasitaemia, antibodies, and antimalarial practices. Bull World Health Organ (1984) 1.36
Immunity to Plasmodium berghei yoelii in mice. II. Specific and nonspecific cellular and humoral responses during the course of infection. J Immunol (1978) 1.32
Lymphatic filariasis on the coast of Ghana. Trans R Soc Trop Med Hyg (1997) 1.32
Circulating epstein-barr virus in children living in malaria-endemic areas. Scand J Immunol (2005) 1.25
Single-dose treatment of Wuchereria bancrofti infections with ivermectin and albendazole alone or in combination: evaluation of the potential for control at 12 months after treatment. Trans R Soc Trop Med Hyg (2000) 1.25
The prevalence of anti-Toxoplasma gondii antibodies in Ghanaian sheep and goats. Acta Trop (2000) 1.25
Structure-activity studies: in vitro antileishmanial and antimalarial activities of anthraquinones from Morinda lucida. Planta Med (1999) 1.24
What is the cause of lymphopenia in malaria? Infect Immun (2000) 1.23
The Role of Variant-specific Immunity in Asymptomatic Malaria Infections: Maintaining a Fine Balance. Parasitol Today (1998) 1.22
Overlapping antigenic repertoires of variant antigens expressed on the surface of erythrocytes infected by Plasmodium falciparum. Parasitology (1999) 1.21
One-stage versus 2-stage bilateral total knee arthroplasty. Clin Orthop Relat Res (1994) 1.20
Lymphatic filariasis related perceptions and practices on the coast of Ghana: implications for prevention and control. Acta Trop (1999) 1.19
Measles epidemic in Harare, Zimbabwe, despite high measles immunization coverage rates. Bull World Health Organ (1991) 1.19
A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana. Trans R Soc Trop Med Hyg (2000) 1.18
Distinct patterns of cytokine regulation in discrete clinical forms of Plasmodium falciparum malaria. Eur Cytokine Netw (2000) 1.17
Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection. Antimicrob Agents Chemother (1994) 1.16
Seasonal variation in agglutination of Plasmodium falciparum-infected erythrocytes. Am J Trop Med Hyg (1998) 1.15
Alkamides from Phyllanthus fraternus. Planta Med (1998) 1.15
Interferon-gamma- and tumour necrosis factor-alpha-producing cells in humans who are immune to cutaneous leishmaniasis. Scand J Immunol (1999) 1.11
Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity. Infect Immun (2001) 1.10
Perturbation and proinflammatory type activation of V delta 1(+) gamma delta T cells in African children with Plasmodium falciparum malaria. Infect Immun (2001) 1.08
Comparative studies of Epstein-Barr virus strains from Ghana and the United States. Int J Cancer (1976) 1.07
Risk factors for the prevalence of malnutrition among urban children in Ghana. J Nutr Sci Vitaminol (Tokyo) (1998) 1.06
High frequency of circulating gamma delta T cells with dominance of the v(delta)1 subset in a healthy population. Int Immunol (2000) 1.06
Plasmodium falciparum: sensitivity to chloroquine in vivo in three ecological zones in Ghana. Trans R Soc Trop Med Hyg (1992) 1.05
Complement binding to erythrocytes is associated with macrophage activation and reduced haemoglobin in Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg (2001) 1.05
Is there a role for gamma delta T cells in malaria? Immunol Today (1992) 1.04
Haptoglobin 1-1 is associated with susceptibility to severe Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg (2000) 1.04
High proportion of subclinical Plasmodium falciparum infections in an area of seasonal and unstable malaria in Sudan. Am J Trop Med Hyg (1995) 1.04
Specific T-cell recognition of the merozoite proteins rhoptry-associated protein 1 and erythrocyte-binding antigen 1 of Plasmodium falciparum. Infect Immun (1993) 1.04
Seasonality of rotavirus infection in Ghana. Ann Trop Paediatr (1994) 1.04
Pregnancy-associated malaria in a rural community of ghana. Ghana Med J (2009) 1.04
Changes in cytokine production associated with acquired immunity to Plasmodium falciparum malaria. Clin Exp Immunol (2001) 1.04
Detection of antigens and antibodies in the urine of humans with Plasmodium falciparum malaria. J Clin Microbiol (1991) 1.04
A longitudinal study of human antibody responses to Plasmodium falciparum rhoptry-associated protein 1 in a region of seasonal and unstable malaria transmission. Infect Immun (1999) 1.03
Acute lower respiratory tract infection in hospitalized children in Zimbabwe. Ann Trop Paediatr (1993) 1.02
Human behavioural factors implicated in outbreaks of human anthrax in the Tamale municipality of northern Ghana. Acta Trop (2000) 1.02
Parents' perceptions, attitudes and acceptability of treatment of childhood malaria with artemisinin combination therapies in ghana. Ghana Med J (2009) 1.02
Type-I HTLV antibody in urban and rural Ghana, West Africa. Int J Cancer (1984) 1.02
Activation of human T lymphocytes by Leishmania lipophosphoglycan. Scand J Immunol (1991) 1.01
Cytokine production and apoptosis among T cells from patients under treatment for Plasmodium falciparum malaria. Clin Exp Immunol (2002) 1.01